Summit Therapeutics (SMMT) Debt to Equity (2022 - 2024)

Summit Therapeutics (SMMT) reported Debt to Equity of $2.26 for Q1 2024, up 201.93% on a YoY basis from $0.75 in Q2 2023, and up 75.73% quarter-over-quarter from $1.29 in Q4 2023.

Summit Therapeutics (SMMT) Debt to Equity (2022 - 2024) Analysis & Trends

Summit Therapeutics has reported Debt to Equity for 3 years, with the latest figure at $2.26 in Q1 2024.

  • For the quarter ending Q1 2024, Debt to Equity rose 201.93% year-over-year to $2.26; the trailing twelve-month figure through Mar 2024 stood at $2.26 (up 201.93% YoY), and the FY2023 full-year result was $1.29, down 67.04% from the prior year.
  • Debt to Equity for Q1 2024 stood at $2.26, up from $1.29 in the prior quarter.
  • The five-year high for Debt to Equity was $3.9 in Q4 2022, with the low at $0.39 in Q1 2022.
  • Historically, Debt to Equity has averaged $1.42 across 3 years, with a median of $0.84 in 2023.
  • Annual changes were most pronounced in 2023 — Debt to Equity sank 67.04% — and 2024, when it jumped 201.93%.
  • Summit Therapeutics' Debt to Equity stood at $3.9 in 2022, then slumped by 67.04% to $1.29 in 2023, then soared by 75.73% to $2.26 in 2024.
  • The last three Debt to Equity figures came in at $2.26 (Q1 2024), $1.29 (Q4 2023), and $0.84 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Summit Therapeutics 10.09 Bn 9.99 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 2.26
Dec 31, 2023 1.29
Jun 30, 2023 0.84
Mar 31, 2023 0.75
Dec 31, 2022 3.90
Jun 30, 2022 0.49
Mar 31, 2022 0.39